3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment

Zhangyi Zhang,Xuebo Chen,Sujie Gao,Xuedong Fang,Shengnan Ren

DOI: https://doi.org/10.1007/s13402-024-00935-9

IF: 7.051

2024-03-25

Cellular Oncology

Abstract:Cancer immunotherapy is receiving worldwide attention for its induction of an anti-tumor response. However, it has had limited efficacy in some patients who acquired resistance. The dynamic and sophisticated complexity of the tumor microenvironment (TME) is the leading contributor to this clinical dilemma. Through recapitulating the physiological features of the TME, 3D bioprinting is a promising research tool for cancer immunotherapy, which preserves in vivo malignant aggressiveness, heterogeneity, and the cell–cell/matrix interactions. It has been reported that application of 3D bioprinting holds potential to address the challenges of immunotherapy resistance and facilitate personalized medication.

oncology,pathology,cell biology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the acquired drug resistance in cancer immunotherapy. Specifically, the paper explores how to construct tumor models through 3D bioprinting technology to overcome immunotherapy resistance, especially by simulating the physiological characteristics of the tumor microenvironment (TME). The following are the key points mentioned in the paper:

1. **Background**:
- Cancer immunotherapy has attracted global attention because it can induce anti - tumor immune responses.
- However, some patients develop acquired drug resistance during the treatment process, resulting in limited treatment effects.
- The dynamics and complexity of the tumor microenvironment (TME) are the main reasons for this clinical problem.

2. **Advantages of 3D bioprinting technology**:
- 3D bioprinting technology can reproduce the physiological characteristics of TME and preserve the invasiveness, heterogeneity and cell - cell/matrix interactions of tumor cells.
- This technology is helpful for studying the interactions between tumor cells and TME, thus providing new ideas for overcoming immunotherapy resistance.

3. **Main contributions**:
- The paper summarizes the contributions of cellular and non - cellular components in TME to the development of immunotherapy resistance.
- It introduces the recent progress of 3D bioprinted tumor models, which serve as platforms for studying the interactions between tumor cells and TME.
- By constructing multi - cellular 3D bioprinted tumor models, the interactions between tumor cells, immune cells, fibroblasts, adipocytes and extracellular matrix (ECM) are reproduced.

4. **Future prospects**:
- In the future, 3D bioprinted tumor models containing patient - derived components can be rapidly prepared to obtain information on tumor immunotherapy resistance in a timely manner and provide references for the clinic.
- Combining organoids or other 3D culture techniques can better simulate the complexity and dynamic changes of the in - vivo tumor microenvironment.

In conclusion, this paper aims to construct more realistic tumor models through 3D bioprinting technology to conduct in - depth research and overcome the acquired drug resistance problem in cancer immunotherapy, providing new tools and methods for personalized medicine.